DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Casopitant is an investigational drug.
There have been 13 clinical trials for Casopitant. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Vomiting, Nausea, and Postoperative Nausea and Vomiting. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Recent Clinical Trials for Casopitant
|A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy||GlaxoSmithKline||Phase 3|
|A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.||GlaxoSmithKline||Phase 3|
|The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects||GlaxoSmithKline||Phase 1|